Free Trial
NASDAQ:BDRX

Biodexa Pharmaceuticals (BDRX) Stock Price, News & Analysis

Biodexa Pharmaceuticals logo
$6.98 +0.28 (+4.18%)
Closing price 08/4/2025 03:59 PM Eastern
Extended Trading
$10.31 +3.33 (+47.71%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biodexa Pharmaceuticals Stock (NASDAQ:BDRX)

Key Stats

Today's Range
$6.62
$7.32
50-Day Range
$6.70
$11.60
52-Week Range
$5.85
$166.93
Volume
36,683 shs
Average Volume
145,749 shs
Market Capitalization
$25.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biodexa Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

BDRX MarketRank™: 

Biodexa Pharmaceuticals scored higher than 2% of companies evaluated by MarketBeat, and ranked 1833rd out of 1,836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Biodexa Pharmaceuticals.

  • Earnings Growth

    Earnings for Biodexa Pharmaceuticals are expected to remain at ($1.25) per share in the coming year.

  • Price to Book Value per Share Ratio

    Biodexa Pharmaceuticals has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.99% of the outstanding shares of Biodexa Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Biodexa Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biodexa Pharmaceuticals has recently increased by 91.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Biodexa Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Biodexa Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.99% of the outstanding shares of Biodexa Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Biodexa Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biodexa Pharmaceuticals has recently increased by 91.64%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Biodexa Pharmaceuticals has a news sentiment score of -0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Biodexa Pharmaceuticals this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Biodexa Pharmaceuticals to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biodexa Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.34% of the stock of Biodexa Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 17.51% of the stock of Biodexa Pharmaceuticals is held by institutions.

  • Read more about Biodexa Pharmaceuticals' insider trading history.
Receive BDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BDRX Stock News Headlines

ADR Ratio Change Effective
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
ADR Ratio Change
Results of Annual General Meeting
See More Headlines

BDRX Stock Analysis - Frequently Asked Questions

Biodexa Pharmaceuticals' stock was trading at $40.50 at the beginning of 2025. Since then, BDRX stock has decreased by 82.8% and is now trading at $6.98.

Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX) announced its quarterly earnings data on Thursday, September, 10th. The company reported ($16,000.00) earnings per share (EPS) for the quarter.

Biodexa Pharmaceuticals's stock reverse split on Thursday, July 31st 2025.The 1-10 reverse split was announced on Tuesday, July 15th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of BDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biodexa Pharmaceuticals investors own include SoundHound AI (SOUN), Dyne Therapeutics (DYN), NVIDIA (NVDA), Viking Therapeutics (VKTX), TRACON Pharmaceuticals (TCON), ASE Technology (ASX) and BigBear.ai (BBAI).

Company Calendar

Last Earnings
9/10/2020
Today
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BDRX
Previous Symbol
LON:MTPH
CIK
1643918
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.75
Quick Ratio
1.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.91 per share
Price / Book
2.40

Miscellaneous

Outstanding Shares
3,654,000
Free Float
3,642,000
Market Cap
$25.50 million
Optionable
Not Optionable
Beta
0.98
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BDRX) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners